Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
histologically confirmed ovarian, primary peritoneal, or fallopian tube cancer;
only 1 previous regimen, which must be platinum-based;
platinum-sensitive disease which is defined by a progression-free interval of greater than 6 months after completion of platinum-based chemotherapy.
You may not be if
previous radiotherapy;
previous treatment with an anti-cancer vaccine or any targeted therapy;
major surgery or traumatic injury within 4 weeks of study;
history or evidence of central nervous system metastases.
Clareo Health | A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
